Skip to content
Search

Latest Stories

Drug use remains stable among adults in England, but frequent use declines

Illicit drug use was more prevalent among young people aged 16 to 24
Man lying on a table due to drug overdose. drug addiction concept.

Illicit drug use was more prevalent among young people aged 16 to 24  

Around 2.9 million people aged 16 to 59 years (8.8 per cent) reported using illicit drugs in the last 12 months as of March 2024, according to the Crime Survey for England and Wales (CSEW).

This figure shows no statistically significant change compared to previous years, with 9.5 per cent in the year ending March 2023 and 8.8 per cent in the year ending March 2014.


However, the number of frequent drug users (more than once a month) aged 16 to 59 fell to 1.8 per cent (approximately 610,000 people), down from 2.3 per cent the year before.

The CSEW data showed that around 150,000 young people aged 16 to 24 years (2.5 per cent) were frequent drug users in the year ending March 2024, a decrease from 4.7 per cent in the  previous year.

Around three-quarters (73.7 per cent) of people aged 16 to 59 years who used any drug in the last year were infrequent users, with half taking them only "once or twice" in the year. Nearly 80 per cent of young people were infrequent users.

Most commonly misused drugs

The CSEW asked questions on the use of specific controlled drugs, including amphetamines, anabolic steroids, cannabis, cocaine (crack and powder), ecstasy, heroin, ketamine, lysergic acid diethylamide (LSD), magic mushrooms, mephedrone, methadone, methamphetamine, nitrous oxide and tranquillisers.

Respondents were asked if they had taken pills or powders (not prescribed by a doctor) or smoked substances (excluding tobacco) without knowing what they were.

Around one million people reported using a Class A drug in the last 12 months, showing no statistically significant change from the previous year.

Class A drugs – cocaine (crack and powder), ecstasy, heroin, LSD, magic mushrooms, methadone and methamphetamine –  are considered to be the most harmful.

There was no change in the prevalence of Class A drug use in the last year for people aged 16 to 59 years or people aged 16 to 24 years.

Cannabis continues to be the most used drug in England and Wales since estimates began in 1995.

In the latest year, cannabis use decreased to around 2.3 million people from around 2.5 million people in the previous year, returning to levels seen a decade ago.

Use of nitrous oxide and crack cocaine slightly decreased, compared with the previous year, but magic mushroom use increased from 0.8 per cent to 1.1 per cent.

Drug use higher among young people  

Illicit drug use was more prevalent among young people, with 16.5 per cent of those aged 16 to 24 (almost 971,000 individuals) reporting any usage during the survey period.

While this represents no statistically significant change compared to the previous year (17.6% in the year ending March 2023), it is much lower than the numbers recorded in the year ending March 2014 (19.1 per cent) and March 2020 (21.0 pr cent).

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less